BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 10657241)

  • 1. Inactivation of cysteine proteases by peptidyl epoxides: characterization of the alkylation sites on the enzyme and the inactivator.
    Albeck A; Kliper S
    Biochem J; 2000 Feb; 346 Pt 1(Pt 1):71-6. PubMed ID: 10657241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidyl epoxides extended in the P' direction as cysteine protease inhibitors: effect on affinity and mechanism of inhibition.
    Perlman N; Hazan M; Shokhen M; Albeck A
    Bioorg Med Chem; 2008 Oct; 16(19):9032-9. PubMed ID: 18789705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of cysteine proteases.
    Govardhan CP; Abeles RH
    Arch Biochem Biophys; 1996 Jun; 330(1):110-4. PubMed ID: 8651683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of cysteine protease inactivation by peptidyl epoxides.
    Albeck A; Kliper S
    Biochem J; 1997 Mar; 322 ( Pt 3)(Pt 3):879-84. PubMed ID: 9148764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 13C-NMR study of the inhibition of papain by a dipeptide-glyoxal inhibitor.
    Lowther J; Djurdjevic-Pahl A; Hewage C; Malthouse JP
    Biochem J; 2002 Sep; 366(Pt 3):983-7. PubMed ID: 12061892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
    Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
    Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic studies on the inactivation of papain by epoxysuccinyl inhibitors.
    Meara JP; Rich DH
    J Med Chem; 1996 Aug; 39(17):3357-66. PubMed ID: 8765519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 1,4-naphthoquinone scaffold in the design of cysteine protease inhibitors.
    Valente C; Moreira R; Guedes RC; Iley J; Jaffar M; Douglas KT
    Bioorg Med Chem; 2007 Aug; 15(15):5340-50. PubMed ID: 17532221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptidyl cyclopropenones: reversible inhibitors, irreversible inhibitors, or substrates of cysteine proteases?
    Cohen M; Bretler U; Albeck A
    Protein Sci; 2013 Jun; 22(6):788-99. PubMed ID: 23553793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azapeptides as inhibitors and active site titrants for cysteine proteinases.
    Xing R; Hanzlik RP
    J Med Chem; 1998 Apr; 41(8):1344-51. PubMed ID: 9548822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aza-peptide epoxides: potent and selective inhibitors of Schistosoma mansoni and pig kidney legumains (asparaginyl endopeptidases).
    James KE; Götz MG; Caffrey CR; Hansell E; Carter W; Barrett AJ; McKerrow JH; Powers JC
    Biol Chem; 2003 Dec; 384(12):1613-8. PubMed ID: 14719804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azadipeptide nitriles: highly potent and proteolytically stable inhibitors of papain-like cysteine proteases.
    Löser R; Frizler M; Schilling K; Gütschow M
    Angew Chem Int Ed Engl; 2008; 47(23):4331-4. PubMed ID: 18404765
    [No Abstract]   [Full Text] [Related]  

  • 13. Potent inhibitors of cysteine proteases from the marine fungus Microascus longirostris.
    Yu CM; Curtis JM; Walter JA; Wright JL; Ayer SW; Kaleta J; Querengesser L; Fathi-Afshar ZR
    J Antibiot (Tokyo); 1996 Apr; 49(4):395-7. PubMed ID: 8642005
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro embryotoxicity of the cysteine proteinase inhibitors benzyloxycarbonyl-phenylalanine-alanine-diazomethane (Z-Phe-Ala-CHN2) and benzyloxycarbonyl-phenylalanine-phenylalanine-diazomethane (Z-Phe-Phe-CHN2).
    Ambroso JL; Harris C
    Teratology; 1994 Sep; 50(3):214-28. PubMed ID: 7871486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. eta(1)-N-succinimidato complexes of iron, molybdenum and tungsten as reversible inhibitors of papain.
    Rudolf B; Salmain M; Martel A; Palusiak M; Zakrzewski J
    J Inorg Biochem; 2009 Aug; 103(8):1162-8. PubMed ID: 19616302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies.
    Wang H; Vath GM; Gleason KJ; Hanna PE; Wagner CR
    Biochemistry; 2004 Jun; 43(25):8234-46. PubMed ID: 15209520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel transglutaminase substrate from Streptomyces mobaraensis inhibiting papain-like cysteine proteases.
    Sarafeddinov A; Arif A; Peters A; Fuchsbauer HL
    J Microbiol Biotechnol; 2011 Jun; 21(6):617-26. PubMed ID: 21715969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteine proteases such as papain are not inhibited by substrate analogue peptidyl boronic acids.
    Martichonok V; Jones JB
    Bioorg Med Chem; 1997 Apr; 5(4):679-84. PubMed ID: 9158866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of papain-like cysteine proteases with dipeptide-derived nitriles.
    Löser R; Schilling K; Dimmig E; Gütschow M
    J Med Chem; 2005 Dec; 48(24):7688-707. PubMed ID: 16302809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and evaluation of in vivo potency and selectivity of epoxysuccinyl-based inhibitors of papain-family cysteine proteases.
    Sadaghiani AM; Verhelst SH; Gocheva V; Hill K; Majerova E; Stinson S; Joyce JA; Bogyo M
    Chem Biol; 2007 May; 14(5):499-511. PubMed ID: 17524981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.